FFRangio Makes a Strong Impression as Wannabe FFR Alternative

Watchdoq May 23, 2025
(MedPage Today) -- A randomized trial laid the groundwork for FFRangio, a proprietary angiography-derived fractional flow reserve (FFR) tool, as a potential gatekeeper for coronary revascularization.
When put to the test in the PROVISION trial...

Read Full Article